WO2011074802A3 - 전립선암 진단용 키트 및 진단방법 - Google Patents

전립선암 진단용 키트 및 진단방법 Download PDF

Info

Publication number
WO2011074802A3
WO2011074802A3 PCT/KR2010/008480 KR2010008480W WO2011074802A3 WO 2011074802 A3 WO2011074802 A3 WO 2011074802A3 KR 2010008480 W KR2010008480 W KR 2010008480W WO 2011074802 A3 WO2011074802 A3 WO 2011074802A3
Authority
WO
WIPO (PCT)
Prior art keywords
kit
prostate cancer
diagnosis method
psa
diagnosing prostate
Prior art date
Application number
PCT/KR2010/008480
Other languages
English (en)
French (fr)
Other versions
WO2011074802A2 (ko
Inventor
윤강준
손영숙
홍현숙
최형원
Original Assignee
주식회사 셀앤바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 셀앤바이오 filed Critical 주식회사 셀앤바이오
Priority to US13/516,460 priority Critical patent/US20120252040A1/en
Priority to EP10837798.7A priority patent/EP2515115A4/en
Priority to JP2012544349A priority patent/JP2013513815A/ja
Priority to CN2010800571972A priority patent/CN102656457A/zh
Publication of WO2011074802A2 publication Critical patent/WO2011074802A2/ko
Publication of WO2011074802A3 publication Critical patent/WO2011074802A3/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G01N33/5304—Reaction vessels, e.g. agglutination plates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 전립선-특이 항원(prostate specific antigen, PSA)에 대한 항체를 사용하여 인간 소변 중의 PSA를 검출하는 것을 포함하는 전립선암 진단용 키트 및 진단방법에 관한 것으로, 보다 구체적으로 PSA에 대한 항체를 포함하고 시료로서 인간 소변이 사용되는 전립선암 진단용 키트, 및 인간 소변 시료를 PSA에 대한 항체와 접촉시켜 PSA를 검출하는 것을 포함하는 전립선암 진단방법에 관한 것이다.
PCT/KR2010/008480 2009-12-17 2010-11-29 전립선암 진단용 키트 및 진단방법 WO2011074802A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/516,460 US20120252040A1 (en) 2009-12-17 2010-11-29 Kit for diagnosing prostate cancer and diagnosis method
EP10837798.7A EP2515115A4 (en) 2009-12-17 2010-11-29 KIT FOR DIAGNOSIS OF PROSTATE CANCER AND DIAGNOSTIC PROCEDURE
JP2012544349A JP2013513815A (ja) 2009-12-17 2010-11-29 前立腺癌診断用キット及び診断方法
CN2010800571972A CN102656457A (zh) 2009-12-17 2010-11-29 用于诊断***癌的试剂盒和方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090126422A KR20110069618A (ko) 2009-12-17 2009-12-17 전립선암 진단용 키트 및 진단방법
KR10-2009-0126422 2009-12-17

Publications (2)

Publication Number Publication Date
WO2011074802A2 WO2011074802A2 (ko) 2011-06-23
WO2011074802A3 true WO2011074802A3 (ko) 2011-10-27

Family

ID=44167817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/008480 WO2011074802A2 (ko) 2009-12-17 2010-11-29 전립선암 진단용 키트 및 진단방법

Country Status (6)

Country Link
US (1) US20120252040A1 (ko)
EP (1) EP2515115A4 (ko)
JP (1) JP2013513815A (ko)
KR (1) KR20110069618A (ko)
CN (1) CN102656457A (ko)
WO (1) WO2011074802A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9575053B2 (en) 2012-03-30 2017-02-21 Kyoto University Urinary biomarker for use in test for prostate cancer
WO2016012925A1 (en) * 2014-07-20 2016-01-28 Sabic Global Technologies B.V. Methods for determining low sulfate concentrations in synthetic urea samples, produced in a manufacturing process and containing high levels of impurities
CN106319070A (zh) * 2016-09-28 2017-01-11 北京致成生物医学科技有限公司 Neurl1b在制备***癌诊断产品中的应用
CN106367526A (zh) * 2016-11-04 2017-02-01 叶伟亮 一种诊断***癌的产品及其应用
IT202000028556A1 (it) * 2020-11-26 2022-05-26 Nib Biotec S R L Metodo per la diagnosi del tumore alla prostata basato sui valori del marcatore psa e di zinco nell’urina
WO2022043890A2 (en) * 2020-08-25 2022-03-03 Nib Biotec S.R.L. Method for the diagnosis of prostate cancer based on the psa marker and zinc values in urine
HUP2100233A1 (hu) 2021-06-16 2023-10-28 Pannon Egyetem Integrált módszer a vizelet prosztata-specifikus antigén N-glikozilációs profiljának kapilláris elektroforézissel történõ meghatározására
CN114184789B (zh) * 2021-12-23 2023-06-16 云南大学 一种***特异性抗原检测探针、一种检测***特异性抗原试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
CN1880958A (zh) * 2005-06-14 2006-12-20 郑州安图绿科生物工程有限公司 酶促化学发光免疫检测***
CN101070345B (zh) * 2006-05-12 2010-09-29 中国科学院上海生命科学研究院 抗***特异抗原psa单克隆抗体及应用
CN101358976A (zh) * 2008-04-28 2009-02-04 北京华大吉比爱生物技术有限公司 检测六项肿瘤标志物的微阵列-酶联免疫检测试剂盒

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DEVERE WHITE R. W. ET AL.: "Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy.", J. UROL., vol. 147, no. 3-2, 1992, pages 947 - 951, XP009169690 *
KLEE, G. G. ET AL.: "Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen.", UROL., vol. 44, no. 1, 1994, pages 76 - 82, XP002697267 *
OBIEZU, C. V. ET AL.: "Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.", J. UROL., vol. 163, no. 3, 2000, pages 802 - 805, XP005371324 *
PANNEX, J. ET AL.: "Molecular forms of prostate-specific antigen and human kallikrein 2 (hk2) in urine are not clinically useful for early detection and staging of prostate cancer.", UROL., vol. 50, 1997, pages 715 - 721, XP027280033 *

Also Published As

Publication number Publication date
KR20110069618A (ko) 2011-06-23
EP2515115A4 (en) 2013-08-21
CN102656457A (zh) 2012-09-05
EP2515115A2 (en) 2012-10-24
US20120252040A1 (en) 2012-10-04
JP2013513815A (ja) 2013-04-22
WO2011074802A2 (ko) 2011-06-23

Similar Documents

Publication Publication Date Title
WO2011074802A3 (ko) 전립선암 진단용 키트 및 진단방법
EP1922326A4 (en) BIOMARKERS USEFUL FOR DIAGNOSING PROSTATE CANCER AND METHOD OF USE THEREOF
WO2010017515A3 (en) Breast cancer specific markers and methods of use
NZ602369A (en) Anti-cxcr1 compositions and methods
MX2013000502A (es) Metodos y kits para el diagnostico de cancer de prostata.
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2012048113A3 (en) Biomarkers of cancer
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2012047618A3 (en) Mesothelioma biomarkers and uses thereof
EP2170075A4 (en) MARKED INHIBITORS OF PROSTATE SPECIFIC MEMBRANEANT (PSMA), BIOLOGICAL ASSESSMENT AND USE AS IMAGING AGENT
WO2011153254A3 (en) Prostate cancer associated circulating nucleic acid biomarkers
WO2011008349A3 (en) Methods of identifying infectious disease and assays for identifying infectious disease
GB0720113D0 (en) Diagnostic, prognostic and predictive testing for cancer
EP3054299A3 (en) Biomarkers for the early detection of breast cancer
WO2009032949A3 (en) High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
TW200801202A (en) Alpha-enolase specific antibody and method of use
WO2007119111A3 (en) Tissue diagnostics for ovarian cancer
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
WO2010115745A3 (en) Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
WO2009111033A3 (en) Detection of biomarkers and biomarker complexes
WO2011087709A3 (en) Eml4-alk translocations in lung cancer
AP2011005905A0 (en) Device and method for the verification and quantitative analysis of analytes, particularly mycotoxins.
WO2010009171A3 (en) Src activation for determining cancer prognosis and as a target for cancer therapy

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080057197.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10837798

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10837798

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 13516460

Country of ref document: US

Ref document number: 2012544349

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2010837798

Country of ref document: EP